ATE401069T2 - Verfahren und materialien zur behandlung von erkrankungen im zusammenhang mit stoffwechselkrankheiten - Google Patents

Verfahren und materialien zur behandlung von erkrankungen im zusammenhang mit stoffwechselkrankheiten Download PDF

Info

Publication number
ATE401069T2
ATE401069T2 AT04801850T AT04801850T ATE401069T2 AT E401069 T2 ATE401069 T2 AT E401069T2 AT 04801850 T AT04801850 T AT 04801850T AT 04801850 T AT04801850 T AT 04801850T AT E401069 T2 ATE401069 T2 AT E401069T2
Authority
AT
Austria
Prior art keywords
methods
amino acid
treating
disclosed
subject
Prior art date
Application number
AT04801850T
Other languages
English (en)
Inventor
Reuben Matalon
Original Assignee
Prekulab Ltd As Af 8 Marts 200
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34193087&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE401069(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Prekulab Ltd As Af 8 Marts 200 filed Critical Prekulab Ltd As Af 8 Marts 200
Application granted granted Critical
Publication of ATE401069T2 publication Critical patent/ATE401069T2/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
AT04801850T 2003-07-28 2004-04-19 Verfahren und materialien zur behandlung von erkrankungen im zusammenhang mit stoffwechselkrankheiten ATE401069T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49047303P 2003-07-28 2003-07-28

Publications (1)

Publication Number Publication Date
ATE401069T2 true ATE401069T2 (de) 2008-08-15

Family

ID=34193087

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04801850T ATE401069T2 (de) 2003-07-28 2004-04-19 Verfahren und materialien zur behandlung von erkrankungen im zusammenhang mit stoffwechselkrankheiten

Country Status (11)

Country Link
US (3) US20050027006A1 (de)
EP (2) EP1920769B1 (de)
CN (1) CN1856300B (de)
AT (1) ATE401069T2 (de)
DE (1) DE602004015115D1 (de)
DK (4) DK1660067T4 (de)
ES (2) ES2310763T3 (de)
PL (2) PL1920769T3 (de)
PT (2) PT1920769E (de)
SI (1) SI1920769T1 (de)
WO (1) WO2005016330A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050027006A1 (en) 2003-07-28 2005-02-03 Reuben Matalon Methods and materials for treating conditions associated with metabolic disorders
US20100317562A1 (en) * 2007-03-23 2010-12-16 Lynn Paolella Dietary Compositions
WO2016003263A1 (en) * 2014-07-01 2016-01-07 N.V. Nutricia Amino acid based diet with improved taste
US11701335B2 (en) * 2018-08-31 2023-07-18 Apr Applied Pharma Research S.A. Methods of normalizing amino acid metabolism
KR20210139274A (ko) * 2019-03-14 2021-11-22 헤모시어 테라퓨틱스, 인크. 유기산혈증을 치료하는 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3832465A (en) * 1971-12-09 1974-08-27 H Ghadimi Injectable amino acid composition commensurate to the anabolic need of the body and method of using same
DE2654820C3 (de) † 1976-12-03 1986-07-31 Maizena Gmbh, 2000 Hamburg Aminosäuregemisch
US4209531A (en) * 1978-09-13 1980-06-24 Children's Hospital Medical Center Method for treating phenylketonuria
US4252822A (en) * 1979-12-26 1981-02-24 Children's Hospital Medical Center Method for treating phenylketonuria
DE3706402C1 (de) 1987-02-27 1988-07-07 Finckh Maschf Siebsegment fuer Filter zum Eindicken von Fasersuspensionen
US5026721A (en) * 1989-06-05 1991-06-25 Dudrick Stanley J Amino acid nutritional supplement and regimen for enhancing physical performance through sound nutrition
DE3926440A1 (de) 1989-08-10 1991-02-14 Voith Gmbh J M Entwaesserungseinrichtung insbesondere banddruckfilter
US5411757A (en) * 1989-11-09 1995-05-02 Buist; Neil R. M. Palatable balanced amino acid-modified diet
DE4037447C2 (de) * 1990-11-24 1994-06-01 Milupa Ag Phenylalaninfreies Diätetikum für juvenile und adulte Personen mit Phenylketonurie sowie ein Verfahren zu seiner Herstellung
AU4842999A (en) 1998-06-30 2000-01-17 Arthrocare Corporation Systems and methods for electrosurgical ablation of viable body structures
US20050027006A1 (en) 2003-07-28 2005-02-03 Reuben Matalon Methods and materials for treating conditions associated with metabolic disorders

Also Published As

Publication number Publication date
US20050027006A1 (en) 2005-02-03
DE602004015115D1 (de) 2008-08-28
WO2005016330A1 (en) 2005-02-24
SI1920769T1 (sl) 2013-07-31
US9820956B2 (en) 2017-11-21
EP1920769B1 (de) 2013-01-16
EP1660067A4 (de) 2006-08-30
EP1660067A1 (de) 2006-05-31
ES2310763T3 (es) 2009-01-16
US8252596B2 (en) 2012-08-28
DK1660067T4 (en) 2017-06-06
EP1660067B2 (de) 2017-03-15
CN1856300A (zh) 2006-11-01
PL1920769T3 (pl) 2013-08-30
EP1660067B1 (de) 2008-07-16
CN1856300B (zh) 2012-04-11
US20120316215A1 (en) 2012-12-13
DK1660067T3 (da) 2008-11-10
DK200600148U3 (da) 2006-10-13
DK1920769T3 (da) 2013-03-25
PT1920769E (pt) 2013-04-10
EP1920769A1 (de) 2008-05-14
US20110038932A1 (en) 2011-02-17
HK1098060A1 (en) 2007-07-13
ES2404049T3 (es) 2013-05-23
PT1660067E (pt) 2008-10-27
DK200600147U4 (da) 2006-10-13
PL1660067T5 (pl) 2018-02-28
PL1660067T3 (pl) 2009-01-30
DK200600147U1 (da) 2006-09-22

Similar Documents

Publication Publication Date Title
WO2002043507A3 (en) Nutrient supplements and methods for treating autism and for preventing the onset of autism
ATE171192T1 (de) Peptide und proteine, verfahren zur ihren herstellung und die verwendung als cholesterol- annehmer
Adibi Renal assimilation of oligopeptides: physiological mechanisms and metabolic importance
BR0314666A (pt) Composição nutricional ou terapêutica utilizável para o tratamento de mamìferos para aumentar a atividade imune e método de tratar um mamìfero para aumentar a concentração de glutationa no tecido no referido mamìfero
JP2011523547A (ja) ペプチド結合トリプトファンとポリペプチド結合トリプトファンの混合物
JP2518692B2 (ja) 筋力持続剤，滋養強壮剤，輸液用剤，栄養補給剤，疲労回復剤及び乳酸生成調節剤
ATE401069T2 (de) Verfahren und materialien zur behandlung von erkrankungen im zusammenhang mit stoffwechselkrankheiten
ID27818A (id) Metode untuk menyediakan glutamin
Gao et al. Molecular docking and antihypertensive effects of a novel angiotensin-I converting enzyme inhibitory peptide from yak bone
DE602004026514D1 (de) Orale Zusammensetzung aus Naturstoffen zum Erhalt der richtigen Hautfeuchtigkeit
ATE373014T1 (de) Einen nanofiltrationsschritt umfassendes verfahren zur aufreinigung von albumin, lösung und zusammensetzung zur therapeutischen anwendung,die dieses enthalten
KR950010884A (ko) 사람 및 동물에서 염증성 반응을 일으키는 공격 또는 패혈증 치료용의 아미노산계 조성물
JP6667194B2 (ja) 脳神経疾患の予防又は脳機能改善用食品を製造するための食品添加物
Hawkins et al. Pyroglutamate stimulates Na+-dependent glutamate transport across the blood–brain barrier
Pencharz Protein and amino acids
DE69834929D1 (de) Verwendung eines organspezifischen ernährungmittels
Kuge et al. Oxidative stress induces the formation of D‐aspartyl residues in the elastin mimic peptides
WO2012085954A1 (en) Combination comprising d-apartic acid and l-arginine or salts thereof for the improvement of cognitive activities and memory in dementia such as dementia senile and alzheimer's disease
JP4702678B2 (ja) 競走馬用飼料添加材
JP2010105931A (ja) シスチン‐ケラチン加水分解物複合体およびその製造方法
CY1113947T1 (el) Μεθοδοι και υλικα για θεραπεια καταστασεων που σχετιζονται με μεταβολικες διαταραχες
WO2005030985A3 (en) Use of amino acid sequences involved in the elongation of fatty acids in identifying and/or developing compounds for preventing and/or treating metabolic diseases
Kamble et al. A Review on Amino Acids. Research & Reviews: A Journal of Drug Design & Discovery. 2021; 8 (3): 19–27p
Miura et al. Long-term consumption of an amino acid diet reduces the pancreatic enzyme secretion response to a trypsin inhibitor in rats
WO2015090906A1 (en) Compositions comprising lysozyme hydrolysate for use in keratin-containing tissue

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1660067

Country of ref document: EP